Immuron Ltd Files 6-K with SEC
Ticker: IMRN · Form: 6-K · Filed: Aug 26, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: IMRN
TL;DR
Immuron Ltd (IMRN) filed a 6-K on 8/26/25, providing updates and confirming it's a foreign private issuer.
AI Summary
Immuron Limited, a pharmaceutical company, filed a Form 6-K on August 26, 2025. This report indicates the company is furnishing information to the SEC as a foreign private issuer, and it does not file annual reports under Form 20-F or 40-F. The filing includes two announcements published by the company in August 2025.
Why It Matters
This filing provides an update on Immuron Limited's activities and disclosures to the U.S. Securities and Exchange Commission, which is important for investors tracking the company's regulatory compliance and recent announcements.
Risk Assessment
Risk Level: low — This filing is a routine disclosure for a foreign private issuer and does not contain significant new financial or operational information that would immediately alter risk.
Key Players & Entities
- Immuron Limited (company) — Registrant
- August 2025 (date) — Reporting period for the Form 6-K
- United States Securities and Exchange Commission (company) — Recipient of the filing
- Form 6-K (document) — Type of filing
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange on which its securities are traded.
Is Immuron Limited filing an annual report on Form 20-F or 40-F?
No, the filing indicates that Immuron Limited files annual reports under cover of Form 20-F, as indicated by the checkmark next to 'Form 20-F'.
Does Immuron Limited furnish information under Rule 12g3-2(b)?
No, the filing indicates 'No' for furnishing information under Rule 12g3-2(b) of the Securities Exchange Act of 1934.
What is the principal executive office address for Immuron Limited?
The principal executive office address for Immuron Limited is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What period does this Form 6-K cover?
This Form 6-K is for the month of August 2025.
Filing Stats: 308 words · 1 min read · ~1 pages · Grade level 18.3 · Accepted 2025-08-26 06:36:23
Filing Documents
- ea0254587-6k_immuron.htm (6-K) — 14KB
- ea025458701ex99-2_immuron.htm (EX-99.2) — 28KB
- ex99-2_001.jpg (GRAPHIC) — 11KB
- ex99-2_002.jpg (GRAPHIC) — 138KB
- ex99-2_003.jpg (GRAPHIC) — 71KB
- ex99-2_004.jpg (GRAPHIC) — 32KB
- 0001213900-25-080490.txt ( ) — 390KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on August 26, 2025 titled: - Immuron partners with InvestorHub A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.2 Immuron partners with InvestorHub 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: August 26, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3